【レポートの概要（一部）】
1. Report Overview
1.1 Rheumatoid Arthritis Overview
1.2 Rheumatoid Arthritis Market Segmentation
1.3 Why You Should Read this Report
1.4 How this Report Delivers
1.5 Main Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQ)
1.9 Some Associated Reports
1.10 About Visiongain
2. What is Rheumatoid Arthritis?
2.1 What Causes Rheumatoid Arthritis?
2.2 How Does the Disease Develop?
2.3 How Can It Be Monitored?
2.4 Can RA Be Cured?
2.5 Performance Criteria Used in Clinical Trials
2.5.1 ACR Criteria For Drug Efficacy
2.5.2 HAQ-DI Measures Daily Activities
2.5.3 mSS Assesses Disease on X-Ray
2.5.4 DAS28 For Disease Severity
2.6 How is RA Treated?
2.6.1 Biologic DMARDs Are the Dominant Source of Revenue
2.6.2 Synthetic DMARDs are the Mainstay of Treatment
2.6.3 Others
2.6.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2.6.3.2 Corticosteroids for Rapid Anti-Inflammatory Effect
2.6.3.3 Analgesics for Rapid Pain Relief
3. World Drug Market for Rheumatoid Arthritis 2016-2026
3.1 The Global Rheumatoid Arthritis Market, 2015
3.2 The Global RA Drugs Market: Revenue Forecast 2015-2026
3.3 The Global RA Drugs Market Segments: Revenue Forecast 2015-2026
3.4 Non-Biologics for RA
3.4.1 NSAIDs: Revenue Forecast, 2015-2026
3.4.2 Synthetic DMARDs: Revenue Forecast, 2015-2026
3.4.3 Others: Revenue Forecast, 2015-2026
3.5 Biologics for RA: Revenue Forecast 2015-2026
4. Leading Drugs in the RA Market 2016-2026
4.1 The Main Drugs in the RA Market, 2015
4.2 Humira: A Major Source of Revenue for AbbVie
4.2.1 Adalimumab Biosimilars
4.2.2 Humira: Revenue Forecast 2015-2026
4.3 Enbrel: Amgen’s Revenue Protected Until 2028
4.3.1 Etanercept Biosimilars
4.3.2 Enbrel: Revenue Forecast 2015-2026
4.4 Remicade: Facing Significant Competition from Biosimilars
4.4.1 Infliximab Biosimilars
4.4.2 Remicade: Revenue Forecast 2015-2026
4.5 Rituxan: Facing Declining Market Share
4.5.1 Rituximab Biosimilars
4.5.2 Rituxan: Revenue Forecast 2015-2026
4.6 Simponi: Market Share Remaining Stable
4.6.1 Simponi: Revenue Forecast 2015-2026
4.7 Orencia: Additional Indications Being Explored
4.7.1 Abatacept Biosimilars
4.7.2 Orencia: Revenue Forecast 2015-2026
4.8 Actemra: First IL-6R Inhibitor Approved for RA
4.8.1 Tocilizumab Biosimilars
4.8.2 Actemra: Revenue Forecast 2015-2026
4.9 Cimzia: Reliable Source of Income for UCB
4.9.1 Certolizumab Biosimilars
4.9.2 Cimzia: Revenue Forecast 2015-2026
4.10 Celebrex: Facing Generic Competition
4.10.1 Celebrex: Revenue Forecast 2015-2026
4.11 Xeljanz: Good Opportunity for Revenue Growth
4.11.1 Xeljanz: Revenue Forecast 2015-2026
4.12 Arcoxia: Sales Revenue Already Declining
4.12.1 Arcoxia: Revenue Forecast 2015-2026
5. Leading National Markets for Rheumatoid Arthritis 2016-2026
5.1 The Leading National Markets in 2015
5.2 The Leading National Markets: Comparison of Revenues and Market Shares to 2026
5.3 The Leading National Markets: Grouped Revenue Forecasts 2016-2026
5.4 The US: Prosperous Economy and Large Patient Population Enables it to Dominate the RA Drugs Market
5.4.1 The US RA Drug Market: Revenue Forecast 2016-2026
5.5 Japan: Remains the Second Largest National Market
5.5.1 The RA Drug Market in Japan: Revenue Forecast 2016-2026
5.6 The EU5 Have 18% Market Share
5.6.1 The RA Drug Market in Germany: Revenue Forecast 2016-2026
5.6.2 The RA Drug Market in France: Revenue Forecast 2016-2026
5.6.3 The RA Drug Market in Italy: Revenue Forecast 2016-2026
5.6.4 The RA Drug Market in Spain: Revenue Forecast 2016-2026
5.6.5 The RA Drug Market in the UK: Revenue Forecast 2016-2026
5.7 China: Expanding Economy with Increasing Market Share
5.7.1 The RA Drug Market in China: Revenue Forecast 2016-2026
5.8 India: Expanding Population Driving Growth
5.8.1 The RA Drug Market in India: Revenue Forecast 2016-2026
5.9 Russia: Expansion Held Back by Troubled Economy
5.9.1 The RA Drug Market in Russia: Revenue Forecast 2016-2026
5.10 Brazil: Focus on Domestic Drug Manufacturing
5.10.1 The RA Drug Market in Brazil: Revenue Forecast 2016-2026
6. Rheumatoid Arthritis R&D Pipeline 2016
6.1 IL-6 Inhibitors Could Rival TNF-Inhibitors
6.1.1 Sarilumab: Already Filed With FDA
6.1.2 Sirukumab: Expected to File in Q3, 2016
6.1.3 Olokizumab: Promising Phase 2 Data
6.1.4 Clazakizumab: Alder Now Collaborating with Vitaeris
6.2 JAK Inhibitors: A Promising Class of Agents
6.2.1 Baricitinib: Potential Competitor to Xeljanz
6.2.2 Peficitinib: Selective JAK-3 Inhibitor From Astellas
6.2.3 ABT-494: Selective JAK-1 Inhibitor From AbbVie
6.2.4 Filgotinib: Following AbbVie’s Withdrawal, Galapagos Now Working with Gilead
6.3 BTK Inhibitors
6.3.1 BMS-986142: Well Tolerated in Phase 1
6.3.2 HM71224: Collaboration with Eli Lilly
6.4 GM-CSF Inhibitor
6.4.1 GSK 3196165: Potential Role in Early Disease
7. Leading Companies in the Rheumatoid Arthritis Drugs Market, 2016
7.1 Introduction to the Leading Companies
7.2 AbbVie: Secured Multiple Patents for Humira
7.3 Roche: Second-Leading Company
7.4 Johnson & Johnson: High Hopes for Sirukumab
7.5 Amgen: Enbrel Sales Protected in the US
7.6 Pfizer: Actively Developing Biosimilars
7.7 Merck & Co.: Remicade Sales in Decline
7.8 BMS: Exploring Additional Indications for Orencia
7.9 UCB: Reliant on Cimzia Revenue
8. Qualitative Analysis of the Rheumatoid Arthritis Drugs Market 2016-2026
8.1 Strengths and Weaknesses of the Rheumatoid Arthritis Market, 2016
8.1.1 Number of Elderly Patients Expected to Rise
8.1.2 Biologics Already Recognised as a Valuable Part of Treatment
8.1.3 Biologics Used in RA Often Have Multiple Indications
8.1.4 Some Patients Have an Inadequate Treatment Response
8.1.5 Efficacy of Drugs Can Diminish Over Time
8.2 Opportunities and Threats Facing the Rheumatoid Arthritis Market, 2016-2026
8.2.1 Need for Effective Drugs With Better Safety Profiles
8.2.2 Need for Less Invasive Routes of Administration
8.2.3 High Number of Products Will Saturate Market
8.2.4 Competition from Biosimilars Will Increase
8.3 Social, Technological, Economic and Political Factors Affecting the Rheumatoid Arthritis Market (STEP Analysis), 2016-2026
8.3.1 Social Factors Influencing the Rheumatoid Arthritis Market
8.3.2 Technological Factors Influencing the Rheumatoid Arthritis Market
8.3.3 Economic Factors Influencing the Rheumatoid Arthritis Market
8.3.4 Political Factors Influencing the Rheumatoid Arthritis Market
8.3.4.1 Government Pressure to Control Costs
8.3.4.2 Inter-country Variability in Biosimilar Approval Process
9. Conclusions
9.1 Global Market for RA Drugs Will Contract After 2018
9.2 Biologics Will Remain the Dominant Drug Class but their Market Share Will Drop By 10%
9.3 Enbrel Will Overtake Humira as the Leading Drug
9.4 US Will Remain the Dominant Market
9.5 Trends in the RA Drugs Market
【レポート販売概要】
■ タイトル：リウマチ性関節炎（RA）治療薬の世界市場2016-2026■ 英文：Rheumatoid Arthritis (RA) Drugs Market 2016-2026
■ 発行日：2016年7月
■ 調査会社：visiongain
■ 商品コード：VGAIN81921
■ 調査対象地域：グローバル
- 重症筋無力症の疫学的予測（～2024）EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024 Summary Myasthenia gravis is an autoimmune disease that affects the nerves and muscles and is characterized by muscle weakness and fatigue, especially weakness of the muscles controlling eye and eyelid movement, facial expression, chewing and talking. In some cases the muscles controlling breathing are also affected, which can lead …
- グローバルWCMS（Webコンテンツ管理システム）市場（2014-2018）About WCMS WCMS is a software tool used to create, manage, store, and deploy content such as text, audio, graphics, videos, and photos, on web pages. This system is used by both technical and non-technical staff to manage the creation of structured web pages. It enhances hosting speed and security, and helps in developing content-rich and error-free websites, establishing a robust multi-channel ma …
- クラウドEメールセキュリティの世界市場2016-2020About Cloud E-Mail Security E-mail security refers to the cumulative measures taken by organizations for securing access to e-mail accounts. Different techniques are used by organizations to detect, monitor, report, and counter threats to e-mail accounts. These techniques include spam filters, digital signing of e-mail messages, strong passwords, and desktop-based anti-virus or anti-spam applicati …
- Dureneの世界市場Durene (CAS 95-93-2) Market Research Report 2013 presents comprehensive data on durene markets globally and regionally (Europe, Asia, North America etc.) The Durene (CAS 95-93-2) Market Research Report 2013 includes durene description, covers its application areas and related patterns. It overviews durene market, names durene producers and indicates its suppliers. Besides, the Durene (CAS 95-93-2) …
- Arsenal Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Arsenal Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Arsenal Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 亜りん酸塩カリウムの世界市場Potassium Phosphite (CAS 13492-26-7) Market Research Report 2013 presents comprehensive data on potassium phosphite markets globally and regionally (Europe, Asia, North America etc.) The Potassium Phosphite (CAS 13492-26-7) Market Research Report 2013 includes potassium phosphite description, covers its application areas and related patterns. It overviews potassium phosphite market, names potassiu …
- SDカードの世界市場2016-2020About Secure Digital Card SD cards are data storage devices used for storing digital information. These cards have non-volatile memory chips that can be reprogrammed multiple times during their life span. Their compact physical size and high storage capabilities with reprogrammable features have increased the penetration of SD cards in the digital world. Different standards for SD cards came into …
- シングルサインオン（SSO）の世界市場予測（～2021）The single sign-on market is estimated to grow from USD 845.6 Million in 2016 to USD 1599.8 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 13.6% during the forecast period. Single sign-on services are gaining importance among the corporates as it adds to the convenience of the user while minimizing the IT administrator’s overhead by reducing instances of password loss. Hence, the adop …
- 軽量素材の世界市場分析：製品別（アルミニウム、高強度鋼、チタン、マグネシウム、ポリマーおよび複合材）、用途別（自動車、航空、エネルギー）、セグメント予測The global lightweight materials market is projected to reach USD 225.35 billion by 2024, according to a new report by Grand View Research, Inc. Positive automotive outlook coupled with increased number of wind project installations is expected to boost demand for these materials. Lightweight materials are gaining popularity in various applications instead of iron and steel on account of improved …
- スマートホーム製品・技術の世界市場：エネルギー管理システム、セキュリティ及び出入制御、エンタテインメント制御、HVAC制御Smart homes refer to a residence equipped with computing and information technology devices that anticipate and respond to the needs of the residents; thus, working towards enhancing their comfort, convenience, security, and entertainment through the automation of technology within a home. Smart homes have already started attracting stakeholders in the market including architects, developers, serv …
- 世界の医療用ガス市場Medical gases include gases used during surgical procedures, medical procedures, sterility purposes and other uses such as coolant. The market has a healthy CAGR and is expected to grow over $16 billion by 2021. The market is driven by various factors such as rise in the number of surgical procedures, number of hospitals, point of care health services and other macroeconomic factor such as health …
- 軍用陸上車の世界市場2015-2019About Military Land Vehicles Military land vehicles include all combat and transportation vehicles used by ground forces. Military land vehicles are an integral part of the army and are used in large numbers by military forces worldwide. Technavio's analysts forecast the global military land vehicles market to grow at a CAGR of 1.40% during the period 2014-2019. [Covered in this Report] This repor …
- ビークルトゥグリッド（V2G）チャージャーの世界市場2018-2022About Vehicle to Grid Chargers Vehicle to grid chargers are EVs chargers that are bi-directional and can be used to charge the vehicle and to transfer energy from the vehicle to charging unit to meet the electricity demand during peak hours. Technavio’s analysts forecast the global vehicle to grid chargers market to grow at a CAGR of 50.05% during the period 2018-2022. Covered in this report The r …
- モバイルプロジェクターの世界市場2017-2021About Pico ProjectorsPico projector is used to project images through a handheld device. These projectors are embedded into several devices, such as smartphones and cameras, and is popular as pico projectors. These are miniature image, video, image, or personal digital assistant (PDA) projectors and are used for several applications such as projecting information on relatively large screens. Techn …
- 移植片対宿主病(Graft Versus Host Disease (GVHD))：治療薬開発パイプライン動向（2015年上半期版）Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with comparative analysis at vario …
